Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38.5M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
+284K
-
Total reported value, excl. options
-
$39.5M
-
Value change
-
+$269K
-
Number of buys
-
17
-
Number of sells
-
-28
-
Price
-
$1.48
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q3 2022
59 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q3 2022.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 38.5M outstanding shares and own 69.37% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.87M shares), Novo Holdings A/S (3.7M shares), Sofinnova Investments, Inc. (2.75M shares), CITADEL ADVISORS LLC (2.75M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.67M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.89M shares), Nan Fung Group Holdings Ltd (1.17M shares), Samsara BioCapital, LLC (1.05M shares), VANGUARD GROUP INC (940K shares), and ORBIMED ADVISORS LLC (771K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.